• DaVita on Oct. 20, 2026, backed the HHS Kidney Care National Plan but rejected suggestions that kidney care lacks innovation.
• It argued that scale supports investment in technology and helps extend care advances to patients more quickly.
• The dialysis provider is deploying a clinical innovation across its centers that it linked to improved clinical outcomes and quality of life.
• It supported earlier detection and slower disease progression, noting 87% of adults with chronic kidney disease are unaware they have it.
• A critical organ shortage remains a barrier to transplantation, with roughly 90,000 Americans on the kidney transplant waiting list.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DaVita Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610201923PR_NEWS_USPR_____LA77323) on October 20, 2026, and is solely responsible for the information contained therein.